FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2949135247> ?p ?o ?g. }

• W2949135247 endingPage "e0200043" @default.
• W2949135247 startingPage "e0200043" @default.
• W2949135247 abstract "Infection of immunocompromised individuals with normally benign opportunistic viruses is a major health burden globally. Infections with viruses such as Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), Kaposi's sarcoma virus (KSHV), adenoviruses (AdV), BK virus (BKPyV), John Cunningham virus (JCPyV), and human papillomavirus (HPV) are significant concerns for the immunocompromised, including when these viruses exist as a co-infection with human immunodeficiency virus (HIV). These viral infections are more complicated in patients with a weakened immune system, and often manifest as malignancies resulting in significant morbidity and mortality. Vaccination is not an attractive option for these immune compromised individuals due to defects in their adaptive immune response. Verdinexor is part of a novel class of small molecules known as SINE (Selective Inhibitor of Nuclear Export) compounds. These small molecules demonstrate specificity for the nuclear export protein XPO1, to which they bind and block function, resulting in sequestration of XPO1-dependent proteins in the nucleus of the cell. In antiviral screening, verdinexor demonstrated varying levels of efficacy against all of the aforementioned viruses including previously with HIV. Studies by other labs have discussed likely mechanisms of action for verdinexor (ie. XPO1-dependence) against each virus. GLP toxicology studies suggest that anti-viral activity can be achieved at a tolerable dose range, based on the safety profile of a previous phase 1 clinical trial of verdinexor in healthy human volunteers. Taken together, these results indicate verdinexor has the potential to be a broad spectrum antiviral for immunocompromised subjects for which vaccination is a poor option." @default.
• W2949135247 created "2019-06-27" @default.
• W2949135247 creator A5037962519 @default.
• W2949135247 creator A5039640673 @default.
• W2949135247 creator A5051352882 @default.
• W2949135247 creator A5078727556 @default.
• W2949135247 date "2018-10-17" @default.
• W2949135247 modified "2023-10-14" @default.
• W2949135247 title "In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals" @default.
• W2949135247 cites W147457896 @default.
• W2949135247 cites W1483476421 @default.
• W2949135247 cites W1598929217 @default.
• W2949135247 cites W1614429408 @default.
• W2949135247 cites W1965637547 @default.
• W2949135247 cites W1984381597 @default.
• W2949135247 cites W1986140437 @default.
• W2949135247 cites W2001007099 @default.
• W2949135247 cites W2008922773 @default.
• W2949135247 cites W2011897382 @default.
• W2949135247 cites W2028885314 @default.
• W2949135247 cites W2035140576 @default.
• W2949135247 cites W2055273020 @default.
• W2949135247 cites W2059949335 @default.
• W2949135247 cites W206720801 @default.
• W2949135247 cites W2082508952 @default.
• W2949135247 cites W2092870774 @default.
• W2949135247 cites W2093710784 @default.
• W2949135247 cites W2108851552 @default.
• W2949135247 cites W2110304220 @default.
• W2949135247 cites W2117838192 @default.
• W2949135247 cites W2124569653 @default.
• W2949135247 cites W2131933513 @default.
• W2949135247 cites W2137596844 @default.
• W2949135247 cites W2148058791 @default.
• W2949135247 cites W2151320496 @default.
• W2949135247 cites W2154749018 @default.
• W2949135247 cites W2159483706 @default.
• W2949135247 cites W2163855907 @default.
• W2949135247 cites W2171258458 @default.
• W2949135247 cites W2293748001 @default.
• W2949135247 cites W2312510557 @default.
• W2949135247 cites W2341614536 @default.
• W2949135247 cites W2514983523 @default.
• W2949135247 cites W2552653876 @default.
• W2949135247 cites W2557351142 @default.
• W2949135247 cites W2558455712 @default.
• W2949135247 cites W2731270140 @default.
• W2949135247 doi "https://doi.org/10.1371/journal.pone.0200043" @default.
• W2949135247 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6192554" @default.
• W2949135247 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30332435" @default.
• W2949135247 hasPublicationYear "2018" @default.
• W2949135247 type Work @default.
• W2949135247 sameAs 2949135247 @default.
• W2949135247 citedByCount "27" @default.
• W2949135247 countsByYear W29491352472018 @default.
• W2949135247 countsByYear W29491352472019 @default.
• W2949135247 countsByYear W29491352472020 @default.
• W2949135247 countsByYear W29491352472021 @default.
• W2949135247 countsByYear W29491352472022 @default.
• W2949135247 countsByYear W29491352472023 @default.
• W2949135247 crossrefType "journal-article" @default.
• W2949135247 hasAuthorship W2949135247A5037962519 @default.
• W2949135247 hasAuthorship W2949135247A5039640673 @default.
• W2949135247 hasAuthorship W2949135247A5051352882 @default.
• W2949135247 hasAuthorship W2949135247A5078727556 @default.
• W2949135247 hasBestOaLocation W29491352471 @default.
• W2949135247 hasConcept C140704245 @default.
• W2949135247 hasConcept C159047783 @default.
• W2949135247 hasConcept C203014093 @default.
• W2949135247 hasConcept C22070199 @default.
• W2949135247 hasConcept C2522874641 @default.
• W2949135247 hasConcept C2776409557 @default.
• W2949135247 hasConcept C2777732132 @default.
• W2949135247 hasConcept C2779820661 @default.
• W2949135247 hasConcept C2780727368 @default.
• W2949135247 hasConcept C86803240 @default.
• W2949135247 hasConcept C8891405 @default.
• W2949135247 hasConceptScore W2949135247C140704245 @default.
• W2949135247 hasConceptScore W2949135247C159047783 @default.
• W2949135247 hasConceptScore W2949135247C203014093 @default.
• W2949135247 hasConceptScore W2949135247C22070199 @default.
• W2949135247 hasConceptScore W2949135247C2522874641 @default.
• W2949135247 hasConceptScore W2949135247C2776409557 @default.
• W2949135247 hasConceptScore W2949135247C2777732132 @default.
• W2949135247 hasConceptScore W2949135247C2779820661 @default.
• W2949135247 hasConceptScore W2949135247C2780727368 @default.
• W2949135247 hasConceptScore W2949135247C86803240 @default.
• W2949135247 hasConceptScore W2949135247C8891405 @default.
• W2949135247 hasFunder F4320337355 @default.
• W2949135247 hasIssue "10" @default.
• W2949135247 hasLocation W29491352471 @default.
• W2949135247 hasLocation W29491352472 @default.
• W2949135247 hasLocation W29491352473 @default.
• W2949135247 hasLocation W29491352474 @default.
• W2949135247 hasLocation W29491352475 @default.
• W2949135247 hasOpenAccess W2949135247 @default.
• W2949135247 hasPrimaryLocation W29491352471 @default.
• W2949135247 hasRelatedWork W1877301543 @default.

• next